Shares

9 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2019

Oct 31, 2019

SELL
$35.66 - $44.99 $213,959 - $269,940
-6,000 Closed
0 $0
Q2 2019

Aug 08, 2019

SELL
$36.57 - $47.97 $676,545 - $887,445
-18,500 Reduced 75.51%
6,000 $261,000
Q1 2019

Apr 24, 2019

BUY
$36.47 - $42.17 $893,515 - $1.03 Million
24,500 New
24,500 $932,000
Q4 2018

Feb 04, 2019

SELL
$41.31 - $52.16 $970,785 - $1.23 Million
-23,500 Closed
0 $0
Q3 2018

Oct 18, 2018

BUY
$32.85 - $52.0 $509,175 - $806,000
15,500 Added 193.75%
23,500 $1.16 Million
Q2 2018

Jul 23, 2018

SELL
$27.5 - $39.8 $530,750 - $768,140
-19,300 Reduced 70.7%
8,000 $0
Q1 2018

May 01, 2018

BUY
$29.98 - $46.35 $539,640 - $834,300
18,000 Added 193.55%
27,300 $850,000
Q4 2017

Jan 24, 2018

BUY
$31.85 - $46.95 $50,960 - $75,120
1,600 Added 20.78%
9,300 $425,000
Q3 2017

Oct 23, 2017

BUY
$35.7 - $39.5 $274,890 - $304,150
7,700
7,700 $289,000

Others Institutions Holding PCRX

About Pacira BioSciences, Inc.


  • Ticker PCRX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 45,824,200
  • Market Cap $892M
  • Description
  • Pacira BioSciences, Inc. provides non-opioid pain management and regenerative health solutions for healthcare practitioners and their patients in the United States. The company offers EXPAREL, a bupivacaine liposome injectable suspension; ZILRETTA, a triamcinolone acetonide extended-release injectable suspension; and iovera system, a non-opioid ...
More about PCRX
Track This Portfolio

Track Mizuho Securities Usa LLC Portfolio

Follow Mizuho Securities Usa LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Mizuho Securities Usa LLC, based on Form 13F filings with the SEC.

News

Stay updated on Mizuho Securities Usa LLC with notifications on news.